U S Physical Therapy INC /NV 8-K filings

U.S. Physical Therapy, Inc. provided an investor presentation on August 12, 2026, detailing its operational performance, strategic growth initiatives, and financial health.

U.S. Physical Therapy announced robust second quarter 2026 results, highlighted by record visit volumes, a strong net rate, and progress in hospital affiliation partnerships.

U.S. Physical Therapy, Inc. announced the acquisition of a twelve-clinic physical therapy practice, effective July 1, 2026, expanding its national footprint.

U.S. Physical Therapy, Inc. shareholders approved director elections, executive compensation, and auditor ratification at the May 19, 2026 Annual Meeting.

U.S. Physical Therapy, Inc. hosted a conference call to discuss its first quarter 2026 results, reporting revenue growth and reaffirming full-year guidance.

U.S. Physical Therapy, Inc. announced record first quarter revenue of $198.3 million, a 7.9% increase year-over-year, while reaffirming full-year guidance.

U.S. Physical Therapy, Inc. has entered into a new $450 million, five-year credit agreement to refinance existing debt and support future growth.

U.S. Physical Therapy, Inc. announces new objective and discretionary incentive plans for senior management for 2026, linking compensation to corporate performance and strategic goals.

U.S. Physical Therapy, Inc. delivered robust financial performance in 2025 with significant EBITDA and revenue growth, driven by record patient visits and strategic acquisitions, while setting the stage for accelerated expansion through new hospital affiliations in 2026 and beyond.

U.S. Physical Therapy, Inc. reported robust financial results for the full year 2025, including significant revenue and EBITDA growth, alongside the announcement of its CFO's resignation and new strategic hospital alliances.

U.S. Physical Therapy, Inc. announced a 10-year strategic alliance with NYU Langone Health and the acquisition of an industrial injury prevention business.

U.S. Physical Therapy, Inc. announced the acquisition of a 50% interest in a physical therapy management services company with eight clinics, generating $8.0 million in annual revenues.

U.S. Physical Therapy, Inc. updated its investor presentation, showcasing strong financial performance, strategic growth initiatives, and a robust market position as of September 30, 2025.

U.S. Physical Therapy, Inc. reported strong third-quarter 2025 results with record patient visits and a positive shift in Medicare reimbursement for 2026.

U.S. Physical Therapy, Inc. announced robust third-quarter 2025 results, driven by significant clinic expansion and double-digit growth in its industrial injury prevention services.

U.S. Physical Therapy, Inc. updated its investor presentation, showcasing strong financial performance, strategic growth, and market leadership in outpatient physical therapy and injury prevention services.

U.S. Physical Therapy, Inc. reported record second-quarter 2025 visits and raised its full-year adjusted EBITDA guidance, driven by strong physical therapy and industrial injury prevention segment performance.

U.S. Physical Therapy, Inc. reported strong second-quarter 2025 results with record patient visits and increased full-year Adjusted EBITDA guidance.

U.S. Physical Therapy, Inc. announced the acquisition of a 60% interest in a physical therapy practice with three clinics, adding approximately $5.3 million in annual revenues and 28,000 annual visits.

U.S. Physical Therapy, Inc. filed an 8-K to disclose the circulation of a research report by Barrington Research Associates, Inc. that includes information attributed to company management.

U.S. Physical Therapy, Inc. has announced a dual listing of its common stock on NYSE Texas, while maintaining its primary listing on the New York Stock Exchange.

U.S. Physical Therapy, Inc. held its annual meeting on May 20, 2025, where shareholders elected directors, approved executive compensation, and ratified the company's accounting firm.

U.S. Physical Therapy, Inc. updates its investor presentation, emphasizing its growth strategy driven by organic expansion, strategic acquisitions, and a strong market position.

U.S. Physical Therapy, Inc. (USPH) announces a strong first quarter in 2025, marked by record visits per clinic per day and significant growth in its Industrial Injury Prevention (IIP) segment, despite ongoing headwinds from Medicare rate cuts.

U.S. Physical Therapy, Inc. (USPH) announced its first quarter 2025 results, highlighting record patient volume and a notable increase in Adjusted EBITDA.

U.S. Physical Therapy, through its subsidiary MSO Metro, has acquired an outpatient home care practice, broadening its service offerings.

U.S. Physical Therapy, Inc. has approved and adopted new incentive plans for its senior management team, effective March 26, 2025, including both objective and discretionary long-term incentive and bonus plans.

U.S. Physical Therapy, Inc. updates its investor presentation, emphasizing its growth strategy and market position.

U.S. Physical Therapy reports a strong fourth quarter and full year 2024, highlighted by a new acquisition in Wyoming and record patient visits, while also navigating cost challenges and Medicare rate reductions.

U.S. Physical Therapy, Inc. (USPH) announces its fourth quarter and full year 2024 results, highlighting record quarterly patient volume and providing earnings guidance for 2025.